Drug Type Diagnostic radiopharmaceuticals |
Synonyms Gallium (68Ga) chloride/Germanium (68Ge) chloride, GeGant |
Target- |
Mechanism Radionuclide imaging enhancers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (01 Aug 2024), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Contrast agents | IS | 01 Aug 2024 | |
Contrast agents | NO | 01 Aug 2024 | |
Contrast agents | LI | 01 Aug 2024 | |
Contrast agents | EU | 01 Aug 2024 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diagnostic agents | Phase 1 | EU | 15 Apr 2024 |